NA
₹132.67
+1.25(+0.95%)
NATHBIOGEN₹132.67+0.95%
58/100
0100 · strongest
good
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %NATHBIOGEN financial summary
For Mar 2026, Nath Bio-Genes (India) Limited reported revenue of ₹345 crore, which grew 30.2% from the previous year. Net profit was ₹44 crore, which grew 4.8% year on year, on an operating margin of 15%. Earnings per share came in at ₹23.38. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹345 crore |
|---|---|
| Net profit | ₹44 crore |
| Operating margin | 15% |
| EPS | ₹23.38 |